4.50
+0.84(+22.95%)
Currency In USD
| Previous Close | 3.66 |
| Open | 4.08 |
| Day High | 4.67 |
| Day Low | 3.48 |
| 52-Week High | 4.67 |
| 52-Week Low | 0.85 |
| Volume | 44.36M |
| Average Volume | 2.23M |
| Market Cap | 205.07M |
| PE | -7.76 |
| EPS | -0.58 |
| Moving Average 50 Days | 2.96 |
| Moving Average 200 Days | 2.13 |
| Change | 0.84 |
If you invested $1000 in Microbot Medical Inc. (MBOT) 10 years ago, it would be worth $4.81 as of September 08, 2025 at a share price of $4.29. Whereas If you bought $1000 worth of Microbot Medical Inc. (MBOT) shares 5 years ago, it would be worth $650 as of September 08, 2025 at a share price of $4.29.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
GlobeNewswire Inc.
9 hours ago
LIBERTY Endovascular Robotic System * Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025 The Company’s Ini
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
GlobeNewswire Inc.
Aug 20, 2025 12:30 PM GMT
With the Newly Granted IP, the Company’s IP Portfolio for the LIBERTY® System now includes 12 patents granted globally and 57 patent applications pending. The Company Continues to Scale Commercial Readiness Plans for the LIBERTY® System as it Awaits
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational Capabilities
GlobeNewswire Inc.
Aug 05, 2025 12:30 PM GMT
Strengthens Balance Sheet and Continues Commercialization Readiness Plans for the LIBERTY® System as it Nears FDA Marketing Clearance DecisionHINGHAM, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the i